Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.5%

1 terminated out of 68 trials

Success Rate

97.2%

+10.7% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

6%

2 of 35 completed with results

Key Signals

2 with results97% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (21)
P 1 (2)
P 2 (2)
P 3 (3)
P 4 (3)

Trial Status

Completed35
Unknown17
Recruiting5
Not Yet Recruiting3
Enrolling By Invitation3
Withdrawn2

Trial Success Rate

97.2%

Benchmark: 86.5%

Based on 35 completed trials

Clinical Trials (68)

Showing 20 of 20 trials
NCT00001159RecruitingPrimary

Natural History of Thyroid Function Disorders

NCT07472062Not ApplicableActive Not Recruiting

Development of a Non-Invasive Prognostic Test for Graves Orbitopathy

NCT07066241Not ApplicableCompleted

Virtual Reality on Stress, Pain Levels in Patients With Hyperthyroidism Undergoing Biopsy

NCT07405320Not ApplicableNot Yet Recruiting

A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment

NCT04856488Phase 3RecruitingPrimary

Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

NCT06098755Not ApplicableWithdrawn

The Sequestration of Holistic Stress Management Techniques for Adults

NCT07369063Phase 2Recruiting

Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

NCT07274670Not ApplicableCompleted

Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery

NCT05774535Withdrawn

Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery

NCT06868459Enrolling By Invitation

Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry

NCT06371339Not ApplicableCompletedPrimary

Optimization With a Gamma Camera of the Individualized Patient Dosimetry in Radioiodine Therapy of Thyroid Diseases

NCT07048548Active Not RecruitingPrimary

Assessment of THL and Potential Risk of Hypothyroidism in Healthcare Workers Exposed to Low-dose Ionizing Radiation

NCT04946123Not ApplicableCompletedPrimary

Hyperthyroidism: Methimazole Plus L-carnitine and Selenium

NCT05252884Not ApplicableCompleted

Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial

NCT06794203Recruiting

Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft

NCT06583395Enrolling By Invitation

Quest to Analyze One Thousand Humans Meditating

NCT06591858Not Yet RecruitingPrimary

Evaluation of Renal Function in Patients With Hyperthyroidism

NCT06570967RecruitingPrimary

A Clinical Study of Hyperthyroidism in Children

NCT06540469Not ApplicableNot Yet Recruiting

Iodine Supplementation in Graves' Hyperthyroidism

NCT06452823Enrolling By Invitation

Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization

Scroll to load more

Research Network

Activity Timeline